MedPath

Cone-beam vs Multidetector Computed Tomography (CT) for Arthrography of the Wrist, Ankle, Elbow and Knee

Not Applicable
Completed
Conditions
Cartilage Ulceration of the Distal Joints
Interventions
Device: CBCT prior to MDCT
Device: MDCT prior to CBCT
Registration Number
NCT01771393
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

ConeBeam scanner (CBCT) is a widely technique used for dental and maxillofacial imaging. Patients can be set up in a sitting or a laying position in the, Newtom 5G CBCT allowing for an analysis of the limbs distal joints. Our hypothesis is that the cone-beam scanner could detect and characterize chondral lesions the cartilage similarly to a multidetector CT (MDCT). 100 patients over 18 years requiring arthroscanner of the wrist, ankle, elbow or knee will be enrolled The primary endpoint based on the ability of cone-beam scanner to detect cartilage lesions. Secondary endpoints will concern the depiction of the joint lesions, quality of the images, tolerability of the exams and inter- intra-operator reproducibility. After arthrography, patients will have a MDCT considered as the reference exam, and a CBCT on a randomized order. Exams will be anonymized and read twice by two trained radiologists with 3-6 week intervals. The inter-observer agreement for the diagnosis of cartilage lesion type between the two techniques will be evaluated by a kappa coefficient. The evaluation of diagnostic performance will be achieved by studying the sensitivity, specificity, negative predictive value and positive predictive value, and its likelihood ratio. Kappa test will be performed to evaluate the consistency of the depiction of the lesions. A Student t test will be performed for paired data if distributions are normal, a Wilcoxon test if not. To assess patient's tolerance, the percentages of (painful, not painful) will be calculated for each technique and will be compared using the Chi2 test (or Fisher's exact test if the chi can not apply).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Patient age 18 years old or above, weight ≤ 160 Kg
  • Patient require knee or ankle or elbow or wrist arthroscanner
  • French spoken an read
  • Free and informed consent signed
  • Being affiliated to a French social security system or similar.
Exclusion Criteria
  • Patients already included in the ARCOBE study
  • Patient with severe pain and reduced spontaneous mobility that could prevent proper positioning for the cone-beam
  • Lack of effective contraception (risk of pregnancy) or pregnancy proven data on interrogations
  • Patient on protection of the court, under supervision or trusteeship
  • Inability to express a consent
  • Patients already enrolled in a study with a conflict of interest with this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CBCT prior to MDCTCBCT prior to MDCTTo avoid systematic bias in performance or image quality due to dilution of the contrast enhancement within the joint, the order of the CBCT and the MDCT will be randomized. This arm is composed of patients who will have the CBCT performed prior to the MDCT.
MDCT prior to CBCTMDCT prior to CBCTTo avoid systematic bias in performance or image quality due to dilution of the contrast enhancement within the joint, the order of the CBCT and the MDCT will be randomized. This arm is composed of patients who will have the MDCT performed prior to the CBCT.
Primary Outcome Measures
NameTimeMethod
cartilage damage thicknessparticipants will be followed for the duration of the arthrography CT , an expected average of 2 hours

0- normal, 1- Linear cartilage tear, 2- focal ulceration of less than 50% of the cartilage thickness, 3-: - focal ulceration of greater than 50% of the cartilage thickness, 4- Full thickness ulceration of the cartilage

Secondary Outcome Measures
NameTimeMethod
cartilage damage measurementsparticipants will be followed for the duration of the arthrography CT , an expected average of 2 hours

Quantitative assessment of each location of cartilage damage by maximal diameter in two orthogonal planes tangential to the surface

Image quality (for CBCT and MDCT)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

0 - Insufficient, 1 - Poor, 2 - Average, 3 - Good, 4 - Excellent

Tolerability of the exam (for CBCT and MDCT)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

Perfect, tolerable, hardly tolerable, intolerable

Duration of the exam (for CBCT and MDCT)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

Perfect, tolerable, hardly tolerable, intolerable

Subchondral bone lesion (for CBCT and MDCT)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

No subchondral bone lesion, subchondral bone thickening, subchondral cyst \<3mm diameter, subchondral cyst 3 to 5 mm diameter, subchondral cyst \>5mm diameter

Lesion of intrinsic ligament (for CBCT and MDCT)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

Yes / No

Osteochondroma (for CBCT and MDCT)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

Each osteochondroma is located (anterior/posterior Medial/ lateral recess, and diameter is measured.: \>3mm, 3 to 5 mm, \>5mm

Meniscal lesion (for arthrography CBCT and MDCT of the knee)participants will be followed for the duration of the arthrography CT , an expected average of 2 hours

No lesion, longitudinal tear, radial tear, complex tear, displaced tear, bucket handle tear

Trial Locations

Locations (1)

Hospices Civils de Lyon- hôpital Edouard Herriot- service de radiologie pavillon B

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath